Table 3 |
|||||
|
List of ion channel genes exhibiting alternative splicing in patients with Alzheimer's Disease |
|||||
| Genes by gene class |
GenBank accession number (reference transcript*) |
GenBank accession number (variant transcript*) |
Alternative splicing event: change of mRNA transcript composition in AD† |
Alternatively spliced region |
Splice array p value |
|
|
|||||
| Calcium channels |
|||||
| CACNA1A |
NM_023035 |
CQ723237 |
ASA: 23% ↓ reference/total ratio |
EXON 23 |
0.007 |
| NM_023035 |
U79668 |
ASD: 36% ↓ variant/reference ratio |
EXON 48 |
0.022 |
|
| CACNA1C |
NM_000719 |
CQ722691 |
ASD: 19% ↑ reference/total ratio |
EXON 27 |
0.033 |
| CACNA1G |
NM_018896 |
NM_198376 |
PIED: 14% ↓ variant/reference ratio |
EXON 36 |
<0.001 |
| CACNA1I |
NM_001003406 |
AX068892 |
ASD: 29% ↓ variant/total ratio |
EXON 16 |
0.049 |
| CACNA2D1 |
NM_000722 |
BG210356 |
NE: 55% ↑ reference/total ratio |
INTRON 3 |
0.021 |
| Chloride channels |
|||||
| CLCN2 |
NM_004366 |
BC021578 |
ES: 14% ↓ reference/total ratio |
EXON 13 |
0.041 |
| NM_004366 |
BF002578 |
NE: 38% ↓ variant/total ratio |
3' downstream |
0.042 |
|
| CLCN6 |
NM_001286 |
NM_021736 |
ES: 15% ↓ reference/total ratio |
EXON 12 |
0.022 |
| CLCNKA |
NM_004070 |
CQ733615 |
ASD: 27% ↓ variant/reference |
EXON 15 |
0.039 |
| Sodium channels |
|||||
| SCN2A2 |
NM_021007 |
CQ730725 |
ES: 16% ↓ variant/total ratio |
EXON 11 |
0.023 |
| SCN7A |
NM_002976 |
BC062699 |
ES: 39% ↓ reference/total ratio |
EXON 1 |
0.027 |
| SCNN1D |
NM_002978 |
AX230571 |
ASA: 17% ↓ variant/reference ratio |
EXON 1 |
0.045 |
| Potassium channels |
|||||
| KCNAB1 |
NM_172160 |
NM_172159 |
NE: 21% ↓ variant/reference |
INITRON 1 |
0.028 |
| KCNAB2 |
NM_003636 |
AI933060 |
NE: 51% ↓ variant/total ratio |
3' downstream |
0.017 |
| NM_003636 |
AI090677 |
NEs: 105% ↑ variant/reference ratio |
INTRON 7 |
0.039 |
|
| NM_003636 |
BM925038 |
PIED: 65% ↑ variant/reference ratio |
EXON 16 |
0.045 |
|
| KCNF1 |
NM_002236 |
AI566537 |
PIED: 51% ↑ variant/reference ratio |
EXON 1 |
0.045 |
| KCNG1 |
NM_172318 |
BF569197 |
ASD: 23% ↓ variant/reference ratio |
EXON 1 |
0.005 |
| NM_172318 |
AI968477 |
ASD: 28% ↑ reference/total ratio |
EXON 1 |
0.031 |
|
| KCNH5 |
NM_172376 |
NM_139318 |
ES: 14% ↑ reference/total ratio |
EXON 11 |
0.033 |
| KCNMB2 |
NM_181361 |
NM_005832 |
NEs: 25% ↓ variant/total ratio |
INTRON 1 |
0.030 |
| KCNN1 |
NM_002248 |
BX106650 |
ASD: 47% ↑ reference/total ratio |
EXON 6 |
0.004 |
| NM_002248 |
BM718136 |
ASD: 39% ↑ reference/total ratio |
EXON 6 |
0.015 |
|
| KCNQ2 |
NM_004518 |
NM_172107 |
NE: 70% ↑ variant/reference ratio |
INTRON 10 |
0.038 |
| NM_004518 |
BG772772 |
NEs: 55% ↑ variant/reference ratio |
EXONS 7-9 |
0.016 |
|
| KCNQ3 |
NM_004519 |
CQ725469 |
PIED: 47% ↓ reference/total ratio |
EXON 15 |
0.036 |
| GABA receptors |
|||||
| GABRA3 |
NM_000808 |
AX897950 |
ES: 48% ↑ reference/total ratio |
EXON 7 |
0.037 |
| GABRA5 |
NM_000810 |
AL035782 |
EsS: 65% ↑ variant/reference ratio |
EXONS 2/3 |
0.030 |
| GABRA6 |
NM_000811 |
AK090735 |
IR: 72% ↓ variant/total ratio |
INTRON 6 |
0.037 |
| Ionotropic glutamate receptors |
|||||
| GRIK2 |
NM_021956 |
CQ715784 |
ASD: 57% ↓ reference/total ratio |
EXON 10 |
0.007 |
| GRIK4 |
NM_014619 |
CQ734018 |
NEs: 35% ↓ variant/total ratio |
INTRON 1 |
0.006 |
| GRIK5 |
NM_002088 |
AJ249209 |
NE: 52% ↑ variant/reference ratio |
INTRON 18 |
0.037 |
| Transient receptor potential cation channels |
|||||
| TRPM7 |
NM_017672 |
CQ728707 |
ES: 6% ↓ reference/total ratio |
EXON 4 |
0.048 |
| FXYD domain ion transport regulators |
|||||
| FXYD5 |
NM_014164 |
BU164524 |
NE: 36% ↓ variant/reference ratio |
INTRON 1 |
0.030 |
| Inositol triphosphate receptors |
|||||
| ITPR1 |
NM_002222 |
CQ719499 |
ES: 15% ↓ reference/total ratio |
EXON 23 |
0.030 |
| Two pore segment channels |
|||||
| TPCN1 |
NM_017901 |
BG899733 |
NE: 49% ↑ variant/reference ratio |
INTRON 1 |
0.016 |
| Mucolipin |
|||||
| MCOLN1 |
NM_020533 |
CA489568 |
ASD: 95% ↑ variant/reference ratio |
EXON 7 |
0.026 |
| NM_020533 |
AJ293659 |
IR: 33% ↑ variant/total ratio |
INTRON 5 |
0.032 |
|
| Ryanodine receptors |
|||||
| RYR1 |
NM_000540 |
CQ717972 |
PIED: 30% ↑ reference/total ratio |
EXON 91 |
0.011 |
| NM_000540 |
CQ730824 |
ES: 35% ↑ variant/reference ratio |
EXON 35 |
0.042 |
|
| Miscellaneous other ion channels/interacting proteins |
|||||
| TM4SF11 (plasmolipin) |
NM_015993 |
R16034 |
NE: 21% ↑ variant/reference ratio |
INTRON 1 |
0.016 |
| GMRP-1 (potassium channel tetramerization protein) |
NM_032320 |
BG722430 |
NE: 26% ↑ variant/reference ratio |
INTRON 1 |
0.031 |
|
|
|||||
|
*Reference transcript refers to traditionally splicing gene product, while the variant refers to the alternatively spliced mRNA transcript. †Change was quantified using splice array samples (control versus AD temporal cortex, n = 10/group). The ratio selected to quantify event was determined based on best available probe choice (see Materials and methods section). ASA, alternative splice acceptor site; ASD, alternative splice donor site; ES, exon skipped; EsS, exons skipped; IR, intron retention; NE, novel exon; NEs, novel exons; PIED, partial internal exon deletion. |
|||||
|
Heinzen et al. Genome Biology 2007 8:R32 doi:10.1186/gb-2007-8-3-r32 |
|||||